Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inder Anand

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 16, 2018
Stable but Progressive Nature of Heart Failure: Considerations for Primary Care PhysiciansInder Anand
Blood|January 3, 2020
How I treat anemia in heart failureInder Anand, Pankaj Gupta
Journal of Cardiac Failure|November 2, 2002
Role of brain natriuretic peptide in the diagnosis and management of heart failure: current conceptsRoberto Latini, Serge Masson, Noeleen de Angelis, et al.
Journal of the American College of Cardiology|January 23, 2004
Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarctionY Chandrashekhar, Soma Sen, Ruth Anway, et al.
Journal of Cardiac Failure|December 11, 2007
Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and functionStein Orn, Cord Manhenke, Iain B Squire, et al.
Advances in Therapy|July 15, 2017
Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart FailureElizabeth Ofili, Inder Anand, Richard Allen Williams, et al.
Journal of the American College of Cardiology|October 24, 2002
Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitorsAldo P Maggioni, Inder Anand, Sidney O Gottlieb, et al.
The Journal of Surgical Research|July 18, 2002
Ischemic preconditioning prior to aortic cross-clamping protects high-energy phosphate levels, glucose uptake, and myocyte contractilityDouglas Baldwin, Y Chandrashekhar, Edward McFalls, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 18, 2013
Improvement of left ventricular diastolic function and left atrial reverse remodeling after catheter ablation of premature ventricular complexesMehmet Akkaya, Henri Roukoz, Selcuk Adabag, et al.
Circulation. Heart Failure|May 10, 2014
Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonistOrly Vardeny, Brian Claggett, Inder Anand, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 16, 2018
Stable but Progressive Nature of Heart Failure: Considerations for Primary Care PhysiciansInder Anand
Blood|January 3, 2020
How I treat anemia in heart failureInder Anand, Pankaj Gupta
Journal of Cardiac Failure|November 2, 2002
Role of brain natriuretic peptide in the diagnosis and management of heart failure: current conceptsRoberto Latini, Serge Masson, Noeleen de Angelis, et al.
Journal of the American College of Cardiology|January 23, 2004
Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarctionY Chandrashekhar, Soma Sen, Ruth Anway, et al.
Journal of Cardiac Failure|December 11, 2007
Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and functionStein Orn, Cord Manhenke, Iain B Squire, et al.
Advances in Therapy|July 15, 2017
Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart FailureElizabeth Ofili, Inder Anand, Richard Allen Williams, et al.
Journal of the American College of Cardiology|October 24, 2002
Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitorsAldo P Maggioni, Inder Anand, Sidney O Gottlieb, et al.
The Journal of Surgical Research|July 18, 2002
Ischemic preconditioning prior to aortic cross-clamping protects high-energy phosphate levels, glucose uptake, and myocyte contractilityDouglas Baldwin, Y Chandrashekhar, Edward McFalls, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 18, 2013
Improvement of left ventricular diastolic function and left atrial reverse remodeling after catheter ablation of premature ventricular complexesMehmet Akkaya, Henri Roukoz, Selcuk Adabag, et al.
Circulation. Heart Failure|May 10, 2014
Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonistOrly Vardeny, Brian Claggett, Inder Anand, et al.
Pageof 11